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Letters to the Editor1960
Lagaaij et al [3] have recently reported that graftsA prospective trial correlating clinical outcomes with
in which the endothelial cells are damaged by vascularADAMTS-13 activity levels will clarify the role of re-
rejection may incorporate host endothelium as part ofplenishing ADAMTS-13 and/or removing inhibitors in
the repair process. They speculate that host endothelialdeterming TMA response to plasma therapy.
cells may be recruited from endothelial stem cells in the
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Endothelial chimerism in
Risk factors for late kidneyassociation with vascular
allograft failurerejection in patients after
To the Editor: We congratulate Ponticelli et al [1] forkidney transplantation an excellent paper regarding the evaluation of risk fac-
tors for late kidney allograft failure that recently ap-
peared in Kidney International. However, we would like
To the Editor: Cell migration from the host to the to suggest to the authors to see for the effect of nephron
transplanted organ results in chimerism in the organ [1]. dosing on late allograft failure. Although the authors
Chimerism may be detected after gender-mismatched have evaluated body mass index (BMI) (25 vs. 25)
organ transplantation with use of fluorescence in situ as a risk factor and found no significant effect. This may
hybridization [2]. To verify the endothelial chimerism, not have become significant as extreme BMI groups were
we studied kidney grafts with immunohistochemistry for not considered separately. Meier-Kriesche et al have
ABO blood-group antigens and in situ hybridization for observed in their study that the relative risk of graft loss
Y chromosome. death censored and uncensored was more in extremes
Four male recipients had received living kidney trans- of BMI compared to other categories. It was evident
that of the extreme groups the relative risk of chronicplants from female donors. The blood type of the recipi-
allograft nephropathy (CAN) was significantly more inents was type A in all cases, and that of donors were
high BMI group [2]. We have observed in our study andtype O in two cases and type B in two cases. Needle
it has been well reported by others that kidneys withbiopsies were performed from 2 to 5 months after kidney
insufficient nephron mass for the recipient may be dam-transplantation and diagnosed as vascular rejection. En-
aged by hyperfiltration injury resulting into proteinuriadothelial cells stained with CD34 were positive for Y
and CAN [3–5]. Thus we feel that if authors can analyzechromosomes, indicating the presence of recipient-type
nephron dosing in addition to other well studied riskmale cells. These endothelial cells were positively stained
factors in this cohort, it would be a significant contribu-for recipient-type blood group A. The patients in the
tion to the literature.
present study have shown that replacement of donor
endothelium by recipient cells does occur in vascular Navalkishor Udgiri, Randeep Kashyap, and Mukut Minz
Chandigarh, Indiarejection after kidney transplantation.
